help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiou, C. Y.
Right arrow Articles by Williams, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiou, C. Y.
Right arrow Articles by Williams, G. H.

Endocrinology, Vol 134, 2371-2375, Copyright © 1994 by Endocrine Society


ARTICLES

The effect of losartan on potassium-stimulated aldosterone secretion in vitro

CY Chiou, I Kifor, TJ Moore and GH Williams
Endocrine-Hypertension Division, Brigham and Women's Hospital, Boston, Massachusetts 02115.

Potassium (K+) and angiotensin-II (Ang-II) are two distinct secretagogues for aldosterone release. However, a local adrenal renin- angiotensin system is present, and several studies suggest a complex interaction between K+ and locally produced Ang-II. First, superfusing zona glomerulosa (ZG) cells with K+ stimulates the secretion of both Ang-II and aldosterone. Second, K(+)-stimulated aldosterone secretion can be reduced in the presence of angiotensin-converting enzyme inhibitors. Because angiotensin-converting enzyme inhibitors are not specific inhibitors of the adrenal renin-angiotensin system, we further tested the hypothesis that locally produced Ang-II participates in K(+)- stimulated aldosterone release from rat ZG cells by using a specific Ang-II antagonist. Although type 1 (AT1) and type 2 (AT2) Ang-II receptors are present in ZG cells, only AT1 antagonist has been shown to mediate Ang-II-induced aldosterone secretion. Losartan, a specific AT1 antagonist, was used in this study. In the presence of losartan (10 microM for 9 mM K+ and 100 microM for 5 mM K+), the average aldosterone secretion during 2 h of superfusion with 9 mM K+ and 5 mM K+ was 70.1 +/- 5.4% (n = 5) and 58.5 +/- 2.2% (n = 3), respectively, of that in its absence. Losartan did not alter the amount of Ang-II secreted. The inhibitory effect of losartan lasted longer than 60 min after it was terminated. In summary, our results support the hypothesis that locally produced Ang-II contributes to the aldosterone secretory response to K+ stimulation at both physiological and supraphysiological levels.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
A. SPAT and L. HUNYADY
Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways
Physiol Rev, April 1, 2004; 84(2): 489 - 539.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. M. Carey and H. M. Siragy
Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation
Endocr. Rev., June 1, 2003; 24(3): 261 - 271.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Mazzocchi, L. K. Malendowicz, A. Markowska, G. Albertin, and G. G. Nussdorfer
Role of adrenal renin-angiotensin system in the control of aldosterone secretion in sodium-restricted rats
Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1027 - E1030.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
U. Hilbers, J. Peters, S. R. Bornstein, F. M. A. Correa, O. Johren, J. M. Saavedra, and M. Ehrhart-Bornstein
Local Renin-Angiotensin System Is Involved in K+-Induced Aldosterone Secretion from Human Adrenocortical NCI-H295 Cells
Hypertension, April 1, 1999; 33(4): 1025 - 1030.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
F. J. Gennari
Hypokalemia
N. Engl. J. Med., August 13, 1998; 339(7): 451 - 458.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. Volpe, B. Gigante, I. Enea, A. Porcellini, R. Russo, M. A. Lee, P. Magri, G. Condorelli, C. Savoia, K. Lindpaintner, et al.
Role of Tissue Renin in the Regulation of Aldosterone Biosynthesis in the Adrenal Cortex of Nephrectomized Rats
Circ. Res., November 19, 1997; 81(5): 857 - 864.
[Abstract] [Full Text]


Home page
HypertensionHome page
B. Gigante, S. Rubattu, R. Russo, A. Porcellini, I. Enea, P. De Paolis, C. Savoia, A. Natale, O. Piras, and M. Volpe
Opposite Feedback Control of Renin and Aldosterone Biosynthesis in the Adrenal Cortex by Angiotensin II AT1-Subtype Receptors
Hypertension, September 1, 1997; 30(3): 563 - 568.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
M. Volpe, S. Rubattu, B. Gigante, D. Ganten, A. Porcellini, R. Russo, M. Romano, I. Enea, M. A. Lee, and B. Trimarco
Regulation of Aldosterone Biosynthesis by Adrenal Renin Is Mediated Through AT1 Receptors in Renin Transgenic Rats
Circ. Res., July 1, 1995; 77(1): 73 - 79.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. Gupta, R. Franco-Saenz, and P. J. Mulrow
Locally Generated Angiotensin II in the Adrenal Gland Regulates Basal, Corticotropin-, and Potassium-Stimulated Aldosterone Secretion
Hypertension, March 1, 1995; 25(3): 443 - 448.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society